Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$0.08 - $0.55 $1,238 - $8,515
15,483 Added 6881.33%
15,708 $1,000
Q1 2023

May 12, 2023

SELL
$1.02 - $1.39 $1,180 - $1,608
-1,157 Reduced 83.72%
225 $0
Q4 2022

Feb 08, 2023

SELL
$1.02 - $1.61 $10,212 - $16,119
-10,012 Reduced 87.87%
1,382 $1,000
Q3 2022

Nov 10, 2022

BUY
$1.28 - $2.91 $14,296 - $32,501
11,169 Added 4964.0%
11,394 $23,000
Q1 2022

May 16, 2022

SELL
$1.03 - $2.01 $2,623 - $5,119
-2,547 Reduced 91.88%
225 $0
Q4 2021

Feb 14, 2022

SELL
$0.98 - $3.06 $2,171 - $6,780
-2,216 Reduced 44.43%
2,772 $3,000
Q3 2021

Nov 15, 2021

BUY
$2.79 - $4.19 $9,176 - $13,780
3,289 Added 193.58%
4,988 $15,000
Q2 2021

Aug 13, 2021

BUY
$2.8 - $3.78 $4,757 - $6,422
1,699 New
1,699 $5,000
Q4 2020

Feb 11, 2021

SELL
$4.12 - $6.29 $2,472 - $3,774
-600 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$4.82 - $8.77 $2,892 - $5,262
600 New
600 $3,000
Q1 2020

May 01, 2020

SELL
$3.18 - $7.0 $14,516 - $31,955
-4,565 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$3.46 - $7.7 $10,348 - $23,030
-2,991 Reduced 39.58%
4,565 $32,000
Q3 2019

Nov 14, 2019

BUY
$2.8 - $3.99 $17,043 - $24,287
6,087 Added 414.36%
7,556 $29,000
Q2 2019

Aug 14, 2019

BUY
$2.34 - $4.28 $3,437 - $6,287
1,469 New
1,469 $6,000
Q1 2019

May 14, 2019

SELL
$3.6 - $8.75 $12,967 - $31,517
-3,602 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$6.25 - $9.2 $22,512 - $33,138
3,602 New
3,602 $28,000

Others Institutions Holding RVLP

# of Institutions
1
Shares Held
92.5K
Call Options Held
0
Put Options Held
0

About RVL Pharmaceuticals plc


  • Ticker RVLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,150,000
  • Description
  • RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...
More about RVLP
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.